# Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)

> **NCT02708732** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 91 (actual)

## Conditions studied

- Diffuse Large B-Cell Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02708732
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-31
- **Primary completion:** 2016-10-31
- **Final completion:** 2016-10-31
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02708732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02708732, "Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02708732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*